CVR number 15132442
Industry 86.9040 Other human health activities

G.B. DAUSCHA ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  3.5% 4.2% 4.2% 4.8% 3.3%  
Credit score (0-100)  55 48 47 44 54  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  1,126 1,143 833 814 761  
EBITDA  95.8 31.6 41.7 249 97.1  
EBIT  72.9 21.0 31.1 248 96.4  
Pre-tax profit (PTP)  59.2 9.6 24.9 243.0 96.0  
Net earnings  40.2 8.4 20.2 193.1 74.1  
Pre-tax profit without non-rec. items  59.2 9.6 24.9 243 96.0  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  4.2 3.0 1.8 0.7 0.0  
Shareholders equity total  -109 -101 -80.7 112 186  
Interest-bearing liabilities  206 113 12.8 0.0 0.0  
Balance sheet total (assets)  376 256 193 271 325  
Net Debt  -87.4 41.1 -97.1 -148 -228  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,126 1,143 833 814 761  
Gross profit growth  2.2% 1.5% -27.1% -2.3% -6.5%  
Employees  2 2 2 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  376 256 193 271 325  
Balance sheet change%  39.7% -32.1% -24.4% 40.4% 19.6%  
Added value  95.8 31.6 41.7 258.2 97.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -46 -21 -21 -2 -1  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  6.5% 1.8% 3.7% 30.4% 12.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  16.1% 5.0% 9.9% 90.8% 32.5%  
ROI %  28.5% 13.2% 49.6% 395.8% 64.9%  
ROE %  12.5% 2.7% 9.0% 126.3% 49.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -22.5% -28.3% -29.5% 41.4% 57.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -91.3% 130.0% -233.1% -59.6% -235.4%  
Gearing %  -188.4% -111.6% -15.9% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  5.4% 7.2% 9.8% 71.8% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.0 0.7 0.7 2.4 2.6  
Current Ratio  1.0 0.7 0.7 2.4 2.6  
Cash and cash equivalent  293.4 71.6 109.9 148.2 228.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -3.3 -111.5 -88.9 152.8 194.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  48 16 21 129 49  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  48 16 21 124 49  
EBIT / employee  36 11 16 124 48  
Net earnings / employee  20 4 10 97 37